QBECO Crohns Disease Clinical Trial

Qu Biologics Begins Research McMaster University to Study New Crohn’s Disease

Qu Biologics

Qu Biologics Begins Research with McMaster University to Study New Crohn’s Disease Research Model, VANCOUVER, BRITISH COLUMBIA We Need IDEAS Dec. 3, 2013 – Qu Biologics Inc., a biopharmaceutical business putting together Specific Immunomodulators (SSIs) that intend to induce the physical body’s invulnerable device versus autoimmune illness and cancer cells, revealed it is teaming up …